Bigstock A new global survey conducted by Merck Animal Health highlights the significant impact of canine allergic skin disease on both dogs and their owners, while revealing ongoing challenges related to diagnosis, treatment, and client-veterinarian communication. The survey, Pet Owner and Vet Perspectives on Canine Pruritus: A Global Survey, gathered responses from 1,710 dog owners and 1,413 veterinarians across 11 countries. Findings showed approximately one-third of canine patients seen by U.S. veterinarians have itchy skin or allergic skin disease, and about two in five dogs with skin conditions are newly diagnosed. Researchers found allergic skin disease can affect the quality of life for both pets and owners. In the United States, 43 percent of owners reported a significant negative impact on their dog’s quality of life, while 34 percent said the condition negatively affected their own well-being. Key findings include: About one-third of canine patients seen by U.S. veterinarians present with itchy skin or allergic skin disease. Two in five dogs with skin conditions are newly diagnosed. Eighty-six percent of U.S. dog owners reported discussing their dog's itch with a veterinarian. Twenty-eight percent of owners and 36 percent of veterinarians in the U.S. reported switching treatments within the past year. “Allergic skin disease is one of the most common clinical signs among dogs of all ages,” says Linda Horspool, BVMS, PhD, DipECVPT, FRCVS, director of scientific marketing affairs at Merck Animal Health, in a press release. The survey also identified communication gaps between veterinarians and pet owners regarding diagnosis, treatment expectations, and long-term management of allergic skin disease. For more information, visit the Merck Animal Health website.
